News Brexit decision hits European pharma shares Shares of leading UK companies have plummeted after the country’s decision to leave the European Union.
News British pharma, biotech reiterate ‘Remain’ support On the eve of the hugely important referendum, the result is too close to call.
Articles Brexit would be a blow for UK life sciences – regulators and... The British public is still split over Brexit – but pharma is warning of potentially serious consequences if the country votes 'Leave' on 23 June. Andrew McConaghie reports.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
